Brickell Biotech Inc
F:VCC2
Fundamental Analysis

Revenue & Expenses Breakdown
Brickell Biotech Inc
Balance Sheet Decomposition
Brickell Biotech Inc
Current Assets | 10.1m |
Cash & Short-Term Investments | 8.7m |
Other Current Assets | 1.4m |
Non-Current Assets | 188k |
PP&E | 124k |
Other Non-Current Assets | 64k |
Free Cash Flow Analysis
Brickell Biotech Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Brickell Biotech Inc
Revenue
|
6.9m
USD
|
Operating Expenses
|
-28.5m
USD
|
Operating Income
|
-21.5m
USD
|
Other Expenses
|
432k
USD
|
Net Income
|
-21.1m
USD
|
VCC2 Profitability Score
Profitability Due Diligence
Brickell Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Brickell Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
VCC2 Solvency Score
Solvency Due Diligence
Brickell Biotech Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Brickell Biotech Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VCC2 Price Targets Summary
Brickell Biotech Inc
Dividends
Current shareholder yield for VCC2 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?